About
Technology
Issues
FAQ
Links
Official Page
PMS61 Rapid Reductions in Fatigue and Sleep Problems and Correlation with Improvements in Patient-Reported Outcomes in Patients with Active RA Treated with Certolizumab Pegol in the realistic 12-Week Phase IIIB Randomised Controlled Study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.